Table 4.
Comparison of patient characteristics by potential side effect recall.
| Characteristic | Recalled potential side effect | P | |
|---|---|---|---|
|
| |||
| No(n=67) | Yes(n=55) | ||
| Female | 35 (52%) | 37 (67%) | 0.09 |
| Crohn’s disease | 34 (51%) | 30 (55%) | 0.68 |
| Aminosalicylates only | 30 (45%) | 11 (20%) | 0.004 |
| Any immunomodulator | 16 (24%) | 22 (40%) | 0.06 |
| Any biologic | 24 (36%) | 24 (44%) | 0.38 |
| Pediatric onset (diagnosis at < 18y old) | 14 (21%) | 12 (23%) | 0.82 |
| Disease duration (years since diagnosis) | 10.0 (6.0, 15.0) | 9.0 (5.0, 16.0) | 0.81 |
P-value from Pearson chi-square test or Wilcoxon rank-sum test. Age at diagnosis is unknown for 2 patients, and disease duration is unknown for 12 patients.